Tola
Dashboards
Five years of performance, at a glance.
Dashboard · 02

Revenue on a clear path to $13.75M

$3.2M
FY26 revenue
First full year across Sephora and tola.co
$13.75M
FY30 revenue
4.3x growth over the five-year plan
44%
Revenue CAGR
Compound annual growth, FY26 to FY30
$10.83M
FY29 revenue
The year the business turns its first profit
24-month forecast — P&L · cash · capital ($ M)

Revenue grows from $3.2M in FY26 to $13.75M by FY30, funded by the Sephora rollout and repeat orders on tola.co.

Dashboard · 03

Profitable from 2029, 28% margins by 2030

2029
First profit year
$10.83M revenue, $2.82M operating profit
$2.82M
FY29 operating profit
26% operating margin in the first profitable year
28%
FY30 operating margin
Margin holds as revenue scales
$3.86M
FY30 operating profit
Self-funded scale without a further raise
24-month use of funds — cash flow ($ M)
Allocation of funds

The plan reaches first operating profit in 2029 and settles near a 28% operating margin by 2030.

Dashboard · 04

Premium pricing holds gross margin above 70%

72-76%
Gross margin
Sustained across the five-year plan
76%
FY30 gross margin
Improves as volume and mix mature
$42-94
Hero price range
Four hero products at mid-prestige tier
2x
DTC margin edge
Online contribution margin vs Sephora wholesale
5-year forecast — $ M (annual)

Mid-prestige pricing and a direct channel keep gross margin in the 72 to 76% range throughout the plan.

Dashboard · 05

Every customer returns four times acquisition cost

$358
Customer LTV
20-month value per customer
$87
Acquisition cost
Blended CAC across Sephora and direct
4.0x
LTV to CAC
Today, before the category crowds
3.25x
FY30 LTV to CAC
Stays healthy as marketing spend scales
Monthly clients — 24 months
Registered base — annual

A $358 customer value against $87 acquisition cost gives a 4.0x return, easing to 3.25x as the brand scales.

Dashboard · 06

Repeat rate climbs from 41% to 65%

41%
Repeat rate today
Customers reordering within 90 days
65%
FY30 repeat rate
As bundle attach and subscription build
+8-12 pts
Subscription lift
Incremental retention from the Q3 2026 launch
1.7x
Bundled reorder rate
Bundle buyers reorder faster than single-product buyers
Revenue by category — 24 months
Revenue by category — annual

Repeat purchase climbs from 41% today to 65% by 2030 as bundles and subscription deepen retention.

Dashboard · 07

From 50-door pilot to 450 doors in 2026

50
Pilot doors
Q4 2025 Sephora pilot
89%
Pilot sell-through
Above the 65 to 70% prestige benchmark
450
2026 rollout doors
Contractually triggered by pilot performance
Q3 2026
Full footprint live
150 doors by Q1, 300 by Q2, 450 by Q3
Per-client economics — annual (SAR)

An 89% pilot sell-through triggered the contracted 450-door Sephora rollout, live in full by Q3 2026.

Dashboard · 08

Two channels, one balanced mix by 2030

1/3
Online (DTC)
tola.co, the retention engine
1/3
Sephora US
The acquisition channel
1/6
US specialty
Credo, Bluemercury, Goop
1/6
International
UK, Middle East, Hong Kong from 2027
Cumulative gross profit — 24m
Gross profit & margin — annual

By 2030 revenue splits roughly one-third online, one-third Sephora US, and one-third specialty and international.

Dashboard · 09

Four hero products, four African bioactives

4
Hero SKUs
One active per product, one complete routine
$42-94
Price range
Marula, Baobab, Kalahari, Rooibos
2 of 4
Clinically backed
IRB studies done, two more queued for 2026
31%
Lead study result
Reduction in moisture loss, Baobab Repair Cream
COGS components — 24 months
COGS components — annual

A focused four-product range at $42 to $94, half of it already carrying completed third-party clinical studies.

Dashboard · 10

Series A funds the path to self-funded scale

$15M
Raise
Series A
$60M
Post-money
Valuation at close
2029
Break-even year
First operating profit, no further raise needed
$13.75M
FY30 revenue
Reached at a 28% operating margin
Marketing spend — 24 months
Marketing spend — annual

The $15M Series A carries the business to first profit in 2029 and self-funded scale by 2030.

Dashboard · 11

Raising $15M at $60M post-money

Series A
Round
Brooklyn-based clinical skincare
$15M
Raise amount
Sized for the Sephora and international waves
$60M
Post-money
Valuation at close
25%
Implied stake
New investor ownership at close
Spend split
Direct vs indirect — annual

TOLA is raising $15M at a $60M post-money valuation, roughly a 25% stake for new investors.

Dashboard · 12

The traction is contracted, not projected

89%
Pilot sell-through
50-door Sephora pilot, Q4 2025
41%
Repeat rate
Reorders within 90 days
450
Doors contracted
2026 rollout triggered by the pilot
2 done
Clinical studies
Third-party IRB, two more queued for 2026
Overheads — 24 months
Overheads — annual

The Sephora rollout, the repeat rate, and the clinical studies are already in hand, not forecast.

Dashboard · 13

A large category asking for exactly this

$19.2B
US premium skincare
2025 market, growing 8.1% a year
$4.8B
Clinical sub-segment
Growing 14% a year, the fastest slice
+71%
Clinical search demand
Year over year, 2023 to 2024
+134%
African-ingredient search
Off a smaller base, same window
Product dev — 24 months
Product dev — annual

TOLA sits in the fastest-growing slice of a $19.2B market where retailers are openly asking for new actives.

Dashboard · 14

Where the plan lands by 2030

$13.75M
FY30 revenue
4.3x the FY26 base
$3.86M
FY30 operating profit
28% operating margin
65%
Repeat rate
Up from 41% today
450+
Retail footprint
Sephora US plus specialty and international
Revenue / employee — annual
Headcount — annual
Salary split — annual

By 2030 the plan reaches $13.75M in revenue at a 28% margin, on a 65% repeat rate and a 450-plus door footprint.